FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282048173> ?p ?o ?g. }

• W4282048173 endingPage "S22" @default.
• W4282048173 startingPage "S22" @default.
• W4282048173 abstract "The United States opioid epidemic combined with the COVID-19 pandemic has demonstrated a 32% rise in non-prescribed fentanyl use and 12.5% rise in heroin use per urine drug test analyses (1). A subset of COVID-19 survivors given inpatient opioids are also being prescribed opioids at discharge. The goal of this investigation is to determine the incidence of chronic opioid use, which is defined as opioid use for 3 months or more, following discharge of in-patient admits for management of COVID-19 with in-patient opioid use in order to evaluate at-risk patient populations and to assess follow-up outcomes following discharge. Following Ochsner Health IRB approval, we performed a retrospective chart analysis of 336 patients with admission for COVID-19 between March 1, 2020 and July 31, 2020 who were treated with in-patient opioids. The following patient data was collected: patient demographics, medical history, comorbidities, in-patient and out-patient opioid prescription data, follow-up visits, and social determinants of health. Patients were followed for 3 months post-discharge. In this cohort, 17.2% patients were prescribed outpatient opioids following discharge and 82.7% patients were not. The patients who continued to receive opioids were predominantly female (62.1%). Of the patients (N = 58) who continued to receive outpatient opioid orders, 13.8% received these prescriptions for COVID-19-related pain with only one patient meeting criteria for ‘chronic opioid use’ with use of three or more months. Out-patient opioid prescriptions in chronic use patients consisted largely of hydrocodone (20.7%) and included oxycodone (12.1%), tramadol (8.6%), and morphine (6.9%). Additionally, of patients who continued to receive opioids following discharge, 69% were Black and 43% had commercial insurance. Additionally, this cohort had a 43% incidence of mental health disorders with anxiety (25.9%) and depression (20.7%) being most commonly cited. Therapeutic opioids used in COVID-19 for myofascial pain must be weighed against the potential risk of abuse. It is suspected that significant trauma or post-surgical pain in conjunction with opioid use in the hospital is associated with the risk of development of chronic opioid use (2-4). In this patient population, only one COVID-19 survivor requiring hospitalization with in-patient opioid use, later developed chronic opioid use. Preliminary data suggests low opioid dependence following its use in COVID-19 patients. Further data refinement and analysis is underway and is necessary to confirm and draw further conclusions. This includes evaluating the role of various patient demographics, significant comorbidities, and opioid characteristics." @default.
• W4282048173 created "2022-06-13" @default.
• W4282048173 creator A5001455877 @default.
• W4282048173 creator A5012771619 @default.
• W4282048173 creator A5017084211 @default.
• W4282048173 creator A5050498714 @default.
• W4282048173 creator A5059252059 @default.
• W4282048173 creator A5077924527 @default.
• W4282048173 date "2022-06-01" @default.
• W4282048173 modified "2023-10-16" @default.
• W4282048173 title "ID:15949 Evaluating Chronic Use of Opioids in COVID-19 Survivors" @default.
• W4282048173 doi "https://doi.org/10.1016/j.neurom.2022.02.153" @default.
• W4282048173 hasPublicationYear "2022" @default.
• W4282048173 type Work @default.
• W4282048173 citedByCount "0" @default.
• W4282048173 crossrefType "journal-article" @default.
• W4282048173 hasAuthorship W4282048173A5001455877 @default.
• W4282048173 hasAuthorship W4282048173A5012771619 @default.
• W4282048173 hasAuthorship W4282048173A5017084211 @default.
• W4282048173 hasAuthorship W4282048173A5050498714 @default.
• W4282048173 hasAuthorship W4282048173A5059252059 @default.
• W4282048173 hasAuthorship W4282048173A5077924527 @default.
• W4282048173 hasBestOaLocation W42820481731 @default.
• W4282048173 hasConcept C118552586 @default.
• W4282048173 hasConcept C126322002 @default.
• W4282048173 hasConcept C167135981 @default.
• W4282048173 hasConcept C170493617 @default.
• W4282048173 hasConcept C1862650 @default.
• W4282048173 hasConcept C194828623 @default.
• W4282048173 hasConcept C2426938 @default.
• W4282048173 hasConcept C2778903686 @default.
• W4282048173 hasConcept C2780035454 @default.
• W4282048173 hasConcept C2781063702 @default.
• W4282048173 hasConcept C2781072394 @default.
• W4282048173 hasConcept C2781118164 @default.
• W4282048173 hasConcept C42219234 @default.
• W4282048173 hasConcept C71924100 @default.
• W4282048173 hasConcept C72563966 @default.
• W4282048173 hasConcept C98274493 @default.
• W4282048173 hasConceptScore W4282048173C118552586 @default.
• W4282048173 hasConceptScore W4282048173C126322002 @default.
• W4282048173 hasConceptScore W4282048173C167135981 @default.
• W4282048173 hasConceptScore W4282048173C170493617 @default.
• W4282048173 hasConceptScore W4282048173C1862650 @default.
• W4282048173 hasConceptScore W4282048173C194828623 @default.
• W4282048173 hasConceptScore W4282048173C2426938 @default.
• W4282048173 hasConceptScore W4282048173C2778903686 @default.
• W4282048173 hasConceptScore W4282048173C2780035454 @default.
• W4282048173 hasConceptScore W4282048173C2781063702 @default.
• W4282048173 hasConceptScore W4282048173C2781072394 @default.
• W4282048173 hasConceptScore W4282048173C2781118164 @default.
• W4282048173 hasConceptScore W4282048173C42219234 @default.
• W4282048173 hasConceptScore W4282048173C71924100 @default.
• W4282048173 hasConceptScore W4282048173C72563966 @default.
• W4282048173 hasConceptScore W4282048173C98274493 @default.
• W4282048173 hasIssue "4" @default.
• W4282048173 hasLocation W42820481731 @default.
• W4282048173 hasLocation W42820481732 @default.
• W4282048173 hasOpenAccess W4282048173 @default.
• W4282048173 hasPrimaryLocation W42820481731 @default.
• W4282048173 hasRelatedWork W2782079232 @default.
• W4282048173 hasRelatedWork W2786925997 @default.
• W4282048173 hasRelatedWork W2896112405 @default.
• W4282048173 hasRelatedWork W2970095446 @default.
• W4282048173 hasRelatedWork W2990296528 @default.
• W4282048173 hasRelatedWork W3006675972 @default.
• W4282048173 hasRelatedWork W4223971192 @default.
• W4282048173 hasRelatedWork W4239819938 @default.
• W4282048173 hasRelatedWork W4323652728 @default.
• W4282048173 hasRelatedWork W4377715595 @default.
• W4282048173 hasVolume "25" @default.
• W4282048173 isParatext "false" @default.
• W4282048173 isRetracted "false" @default.
• W4282048173 workType "article" @default.